siRNA, Anti-ATP2A2, LNA-modified(CAT#: SIRGT04327WQ-LNA)

The product SIRGT04327WQ-LNA is a type of small interfering RNA (siRNA) that targets ATP2A2 gene and regulates the expression of gene. The siRNA interferes with the expression of ATP2A2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001681.3; NM_170665.3
Alternative Names ATP2B; DAR; DD; SERCA2
Related Diseases Acrokeratosis Verruciformis, Darier-White Disease
Purification HPLC
Target Gene
Gene ID 488
Uniprot ID P16615

Related Products